Novo Integrated Sciences Inc(NVOS)
USD --+0.00%
Reward49Moderate
Risk74High
📊75%Data
Thin -122% profit margin · Revenue down 7% YoY
NVOS
+0.0 · +0.00%
USD · NASDAQ
Novo Integrated Sciences Inc | Healthcare
Earnings Deterioration
Market Cap:61163
ℹ️
Reward Rating
49
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
74
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on NVOS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Novo Integrated Sciences Inc?

, together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada.

NVOS · Verdict

Moderate reward · high risk

NVOS's standout is valuation; profitability and balance sheet weigh on the picture.

Based on 88% data coverage

NVOS · Verdict

What’s working & what to watch

Strengths 1

  • Valuation67/100

    Above average

Watchouts 4

  • Profitability19/100

    -121% net margin · -82% ROE

  • Balance sheet19/100

    Current ratio 0.37

  • Cash flow29/100

    -17% free-cash-flow margin

  • Volatility35/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Novo Integrated Sciences Inc?

, together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 61.16K.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (49)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap61.16K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.07
52 Week Low0.0001
Last AnnualAugust
IPO Date9/22/2017
IncorporatedUSA
Shares Outstanding20M
No. of Employees115
IndustryMedical Care Facilities
ExchangeNASDAQ
Beta1.398
CurrencyUSD